Woodline Partners LP 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | SAB Biotherapeutics, Inc. SABS | Woodline Partners LP | 7,125,881 9.900% | 7,125,881 (New Position) | Filing |